Effects of Rosiglitazone and Alpha-lipoic Acid on the Patients With Pathologically Proved NASH
Status:
Terminated
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
This study is to evaluate the effects of Rosiglitazone, insulin sensitizer and alpha-lipoic
acid, antioxidant on patients with pathologically proved NASH (non-alcoholic
steato-hepatitis).